The Business of BrainHealth: Washington DC, Oct 13th (VC, GTM, Monetization)

​BrainHealth innovation can be difficult to scale. It scales when Founders, clinicians, investors, operators, regulators and budget owners challenge one another to think bigger, reduce friction and demonstrate substantial ROI. On Tuesday, October 13th, 5pm, 1700 Pennyslvania Avenue NW, Suite 900, Washington DC, join an information-packed session. confirmed speakers: ​Moderator: Richard Hatzfeld, Co-Lead, Global Health Impact, FINN Partners ​ VC Roundtable: ​Dr. Maria Blekher, Managing Partner, Serendipity Impact VC Elena Serlin, Founder, 3L Todd Haim, Investment Dirctor, National Institute on Aging (NIA) ​Go-To-Market Keynote: Esther Howard, CEO, Bezyl ​Reimbursement Keynote: David Farber, FDA and Life Sciences Reimbursement Partner, King & Spalding ​Don't miss this chance to meet investors and practitioners with proven track records of success. Light snacks and beverages provided. The discussion will be recorded and posted for later viewing. ​ Secure your spot for "BrainHealth- Investment, GTM, Monetization", Tuesday, October 13th, 5:30pm at King & Spalding, 1700 Pennsylvania Avenue NW, Suite 900. Please bring ID for security check-in.ession focused on investment, reimbursement and go-to-market strategies that will transform your business.